According to a study conducted by the National Institute of Neurological Disorders and Stroke, and published today in the journal Neurology, regular users of ibuprofen are 40% less likely to develop Parkinson’s disease than others.
The study also reveals that people who consume ibuprofen in large quantities are less likely to develop Parkinson’s disease than people who consume little.
The study was conducted on 136,474 people who did not have Parkinson’s disease. The researchers compiled lists for each participant indicating whether or not they were taking anti-inflammatories (aspirin, ibuprofen, or paracetamol). After six years, 293 of the participants developed Parkinson’s disease.
“Ibuprofen is the only anti-inflammatory that had a positive impact on Parkinson’s disease. Other anti-inflammatory drugs had no influence on the disease. Further research is needed to understand why and how ibuprofen can have an effect on this disease”, explains Doctor Xiang Gao.